FDA warns some antibiotics can cause fatal heart damage ~ Oct. 20, 2022

________________________________________________________________________________________________

AntibioticsLinkedtoFatalHeartCondition

Thisantibioticcontributestorisingproblemswithantibiotic-resistantbacteria,kidneystonesandpsychoticepisodes;datademonstratesitincreasesyourriskofafatalheartcondition

.Dr.JosephMercola

Fluoroquinolones, long associated with Achilles tendonitis and rupture, have beendemonstrated to increase your risk of aortic dissection (a tear in the wall of the majorartery, allowing blood to ow between the layers) or aortic rupture, which can lead to death

Even though “black-box” warnings are now attached to them, uoroquinolones are stilloen prescribed for upper respiratory infections or urinary tract infections

STORYAT-A-GLANCE

Antibiotic use can trigger a permanent change in your gut microbiome, which accounts fornearly 80% of your immune system function, so it is important to use antibiotics only whenabsolutely necessary

You may reduce your risk of bacterial and viral infections by supporting your immune system through simple lifestyle measures, such as quality sleep, fermented foods, regularexercise and optimizing your vitamin D level.

Research shows your body’s microbiome has nearly 39 trillion bacteria. During early years, yourmfamily, dietary intake and environmental exposure contribute to the variety in your microbiome,influencing your lifelong health. Everyday activities such as brushing your teeth, eating, kissing someone or handling a family pet also affect your microbiome.

This composition may be as distinct to you as a fingerprint and plays an enormous role in

disease prevention, and influences the function of your skin, lungs, breast and liver. Harmful

bacteria can trigger illness and disease, which is frequently treated with antibiotics. Of the 10

most commonly prescribed, two are from the antibiotic class of uoroquinolones.The Food and Drug Administration (FDA) rst added a boxed warning to floroquinolones in2008, due to the increased risk for tendinitis and tendon rupture.

Boxed warnings, also referred to as black box warnings, appear on prescription drug labels designed to call attention to serious or life-threatening risks.

An additional warning was added in 2011 for those suffering from myasthenia gravis, and updates were included in 2013 describing irreversible peripheral neuropathy.

In 2018, the FDA warned fluoroquinolone antibiotics may increase the occurrence of ruptures or tears in theaorta. And, in January 2022, the FDA decided.

“We have determined that uoroquinolones should be reserved for use in patients with no other treatment options for acute bacterial sinusitis, or ABS, acute bacterial exacerbation of chronic bronchitis (ABECB), and uncomplicated UTI because the risks generally outweighs the benefits.

For some serious bacterial infections the benefits of fluoroquinolones outweigh the risks, and it isappropriate for them to remain available as a therapeutic option.”

Yet, despite these warnings, researchers found in April 2022 that fluoroquinolones are stillmamong the most-prescribed antibiotics around the world. They concluded that some health careworkers may have an “unsatisfactory knowledge” of the safety proles and risks of these drugs,and that more education on adverse reactions to fluoroquinolones may be needed.

The aorta is the main artery in your body supplying oxygenated blood to your circulatory system.The artery comes from the left side of your heart and runs down the front of your backbone. The review by the FDA found fluoroquinolone antibiotics increase the risk of tears in the aorta, also called aortic dissections, or ruptures of an aortic aneurysm, leading to excessive bleeding and death.

The findings occurred when antibiotics were given by mouth or through an injection. This led the FDA to caution against the use of fluoroquinolone antibiotics in those at risk, unless there are no other treatment options available.

Specically, the antibiotic should not be used in those who are at risk for, or have a current, aortic aneurysm, such as those suffering peripheral atherosclerotic vascular disease,hypertension and specic genetic conditions such as Ehlers-Danlos syndrome or Marfansyndrome.

Findings were pulled from four published observational studies, which taken together

demonstrated a consistent association between aortic dissection or rupture and fluoroquinoloneuse. The underlying mechanism could not be determined from those studies.Some of the commonly used fluoroquinolones include ciprooxacin (Cipro), levooxacin(Levaquin), gemioxacin (Factive) and moxioxacin (Avelox). These are prescribed to treat upper respiratory and urinary tract infections. In a statement, the FDA warns:

FDAWarningLinksFluoroquinolonesWithAortic

Leave a comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.